PREMORBID BRAIN SIZE AS A DETERMINANT OF RESERVE CAPACITY AGAINST INTELLECTUAL DECLINE IN ALZHEIMERS-DISEASE

Citation
E. Mori et al., PREMORBID BRAIN SIZE AS A DETERMINANT OF RESERVE CAPACITY AGAINST INTELLECTUAL DECLINE IN ALZHEIMERS-DISEASE, The American journal of psychiatry, 154(1), 1997, pp. 18-24
Citations number
49
Categorie Soggetti
Psychiatry,Psychiatry
ISSN journal
0002953X
Volume
154
Issue
1
Year of publication
1997
Pages
18 - 24
Database
ISI
SICI code
0002-953X(1997)154:1<18:PBSAAD>2.0.ZU;2-K
Abstract
Objective: Both the magnitude of brain atrophy and premorbid brain siz e determine the volume of the brain affected by Alzheimer's disease. T o examine the possibility that premorbid brain volume is a determinant of cognitive reserve in patients with Alzheimer's disease, the relati on between diffuse brain atrophy and cognitive decline and the impact of premorbid brain size on cognitive decline were studied in patients with Alzheimer's disease. Method: By measuring whole brain volume and intracranial volume in 60 patients with probable Alzheimer's disease, mild to moderate in severity, with the use of high-resolution magnetic resonance imaging and image processing, the authors studied the impac t of premorbid brain volume and magnitude of diffuse brain atrophy on cognitive functions. On the basis of the normative brain-calvarium rel ationship derived from data an 28 healthy adults and the total intracr anial volume measure of each patient, the magnitude of brain atrophy a nd premorbid brain volume were estimated. Results: After control for t he effects of age, sex, and education as confounding factors, it was f ound that the Alzheimer's disease patients' intelligence was correlate d both positively with premorbid brain volume and negatively with magn itude of brain atrophy, while impairments in language and memory were correlated with magnitude of brain atrophy but not with premorbid brai n volume. Conclusions: These findings partially support the hypothesis that premorbid brain volume is a determinant of reserves against inte llectual decline in Alzheimer's disease.